Media Buys False “Blind Trust” Excuse for Suspicious Kerry Stock Trades

With details now erupting on Capitol Hill about Sen. John Kerry’s (D-MA) questionable investments, a curious question lingers: why did it take a Tallahassee-based think tank wonk to uncover a former presidential candidate’s aggressive trading of pharmaceutical stock during both the 2009 Obamacare debate and the 2003 prescription drug benefit plan debate?  Continue reading on BigJournalism.com.